Requirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human retroviruses human T-cell lymphotropic virus I and HIV-1
about
Molecular cloning of a novel human I-mfa domain-containing protein that differently regulates human T-cell leukemia virus type I and HIV-1 expressionA cofactor, TIP30, specifically enhances HIV-1 Tat-activated transcriptionPITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo.Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stagesRelief of two built-In autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoterhnRNP U inhibits carboxy-terminal domain phosphorylation by TFIIH and represses RNA polymerase II elongationTranscriptional cofactor CA150 regulates RNA polymerase II elongation in a TATA-box-dependent mannerCoordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcriptionTIP30 has an intrinsic kinase activity required for up-regulation of a subset of apoptotic genesThe HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase IIThe expanding role of Tax in transcriptionThe HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitroTat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcriptionTat-associated kinase (P-TEFb): a component of transcription preinitiation and elongation complexesRequirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcriptionC-terminal domain phosphatase sensitivity of RNA polymerase II in early elongation complexes on the HIV-1 and adenovirus 2 major late templatesTFIIH inhibits CDK9 phosphorylation during human immunodeficiency virus type 1 transcriptionActivation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 TatRegulation of carboxyl-terminal domain phosphatase by HIV-1 tat proteinRNA Polymerase II C-Terminal Domain: Tethering Transcription to Transcript and TemplateTranscription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitroP-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase IIRegulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.Adhesion of renal carcinoma cells to endothelial cells depends on PKCmu.Mechanism and regulation of transcriptional elongation by RNA polymerase II.Multifaceted activities of the HIV-1 transactivator of transcription, Tat.Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat.Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell linesHuman and rodent transcription elongation factor P-TEFb: interactions with human immunodeficiency virus type 1 tat and carboxy-terminal domain substrate.Human GLI-2 is a tat activation response element-independent Tat cofactor.Tat activates human immunodeficiency virus type 1 transcriptional elongation independent of TFIIH kinase.Tat and trans-activation-responsive (TAR) RNA-independent induction of HIV-1 long terminal repeat by human and murine cyclin T1 requires Sp1.Tax interacts with P-TEFb in a novel manner to stimulate human T-lymphotropic virus type 1 transcription.Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin TEvaluation of in vitro and in vivo anti-inflammatory activity of biologically active phospholipids with anti-neoplastic potential in porcine model.A novel binding pocket of cyclin-dependent kinase 2.Nuclear Factor 90(NF90) targeted to TAR RNA inhibits transcriptional activation of HIV-1.Inhibition of protein kinase C epsilon causes ciliated bovine bronchial cell detachmentRecruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.Promoter activity of Tat at steps subsequent to TATA-binding protein recruitment.
P2860
Q22253171-0245E264-FD66-4555-9917-5FEB1B4372DDQ24314052-FC5EEF4C-BC02-4504-B088-EB7DA28DB675Q24523183-D66969C7-EA02-489B-B62A-654E547FDC87Q24533266-7CBCE939-72A8-4F72-BFEC-86E61F211428Q24552532-1B801EFF-0745-4F39-96B9-B982F506D8C7Q24554421-30D9E45A-BE5A-4CDE-98D4-481A0181C2CBQ24554483-B36C85FD-A0FB-486E-AB90-7A46A68D28EEQ24559797-FBFC9AEB-42FE-4813-BF10-7847C7ED392CQ24600874-75772A81-4827-4E87-AB0C-7AD7D4D0F002Q24605935-6C21F698-61D2-4E0D-AB10-062819023A7FQ24797204-E8E15A44-3D4E-4013-8919-86BC2599BED2Q27486255-21C735D5-41AF-403D-BF73-5D3997E8BE3EQ28116305-F9FE7605-BAC7-4774-95D9-140185B97AE8Q28138220-ADCD36BC-FE8A-4042-AEC8-376B21AF3655Q28141637-F35A92AE-D8B8-46C7-80D7-DC1E0EDD59F9Q28143301-13480E97-CA17-4CF2-B51A-0147A96E67CBQ28188877-CB2C29F8-6753-4CC4-8FCC-4226BEBFCB64Q28282041-61162A8D-DFDA-4952-B537-4A3572B3891AQ28289216-E6DCA74B-9E11-4362-9018-C72CBD9FE62BQ29540749-0A453E05-9D3B-4B9D-9D10-B9A4A14D944DQ29614788-2EB49A2D-276F-4B9D-87E7-39A14953DBE3Q29620167-59785B35-9F08-4A9F-90ED-73456C1EBB0FQ30350982-5044472C-0598-48C7-94BC-5311837CCF17Q33575037-2D8E637B-3FB8-4195-B0A0-141A195E6746Q33680820-D804058F-34AD-4965-AD7B-D1EE486EDD1AQ33743566-8970E5AE-6392-4F8C-8225-677373910AA0Q33782959-11FFA245-177B-4BA4-923A-043E84E4076DQ33786066-50C7785D-8726-421C-97AB-83D7BB588898Q33815080-2BF7377F-F0EC-4B86-8CCD-33F7DA3BF5CBQ33850701-910FF359-C82D-4A08-9F2B-36DA7EA76375Q33957746-6E7FB078-C09B-426A-85D7-FBE1CA70F676Q34161703-8A82C79D-35AC-462E-B385-FAAA77260906Q34647848-5AFA702A-CFD2-4FB1-BC79-FD38DB7B1371Q34987620-DEFC6D5B-7F10-4CF2-9C2B-B0D5D0F88CE4Q35262922-F2324409-2B9D-4E74-B7E3-B9AD79921433Q35835565-02383F77-A0CD-4172-9098-084B226F1555Q35874904-F4FA9DFD-8B15-49BF-B0E4-64A41DCC1D81Q36178645-BF39F2ED-CE78-4BEA-A5E8-7308D929CD23Q36405698-512CC7BB-50B8-4C47-9F90-AE3E06EDDAA6Q36573810-23A956FA-B9DC-4CFF-9AC8-D435CCBEF1A4
P2860
Requirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human retroviruses human T-cell lymphotropic virus I and HIV-1
description
1996 nî lūn-bûn
@nan
1996 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Requirements for RNA polymeras ...... lymphotropic virus I and HIV-1
@ast
Requirements for RNA polymeras ...... lymphotropic virus I and HIV-1
@en
Requirements for RNA polymeras ...... lymphotropic virus I and HIV-1
@nl
type
label
Requirements for RNA polymeras ...... lymphotropic virus I and HIV-1
@ast
Requirements for RNA polymeras ...... lymphotropic virus I and HIV-1
@en
Requirements for RNA polymeras ...... lymphotropic virus I and HIV-1
@nl
prefLabel
Requirements for RNA polymeras ...... lymphotropic virus I and HIV-1
@ast
Requirements for RNA polymeras ...... lymphotropic virus I and HIV-1
@en
Requirements for RNA polymeras ...... lymphotropic virus I and HIV-1
@nl
P2860
P356
P1476
Requirements for RNA polymeras ...... lymphotropic virus I and HIV-1
@en
P2093
P2860
P304
P356
10.1074/JBC.271.44.27888
P407
P577
1996-11-01T00:00:00Z